Tratamiento del tabaquismo en la enfermedad pulmonar obstructiva crónica

Anthonisen, 1994, Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study, JAMA, 272, 1497, 10.1001/jama.1994.03520190043033 2012, Arch Bronconeumol, 48, 2 Sobradillo Peña, 2000, Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study, Chest, 118, 981, 10.1378/chest.118.4.981 Miravilles, 2009, Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities, Thorax, 64, 863, 10.1136/thx.2009.115725 Estrategia en EPOC del Sistema Nacional de Salud. Madrid: Ministerio de Sanidad y Política Social; 2009. Jiménez Ruiz, 2012 Anthonisen, 2005, The effects of a smoking cessation intervention on 14,5-year mortality: a randomized clinical trial. Health Study Research Group, Ann Inter Med, 142, 233, 10.7326/0003-4819-142-4-200502150-00005 Fiore, 2008 Jarvis, 1980, Expired air carbon monoxide: a simple breath test of tobacco smoke intake, Br Med J, 281, 484, 10.1136/bmj.281.6238.484 Laniado-Laborin, 2009, Smoking and chronic obstructive pulmonary disease (COPD). Parallel Epidemics of the 21st Century, Int J Environ Res Public Health, 6, 209, 10.3390/ijerph6010209 Van der Meer, 2008 Jiménez-Ruiz, 2001, Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD, Chest, 119, 1365, 10.1378/chest.119.5.1365 Shahab, 2006, Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample, Thorax, 61, 1043, 10.1136/thx.2006.064410 Hilberink, 2006, Characteristics of patients with COPD in three motivational stages related to smoking cessation, Patient Educ Couns, 61, 449, 10.1016/j.pec.2005.05.012 Tashkin, 2001, Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial, Lancet, 357, 1571, 10.1016/S0140-6736(00)04724-3 Coronini-Cronberg, 2011, Effective smoking cessation interventions for COPD patients: a review of the evidence, J R Soc Med Sh Rep, 2, 78 Tashkin, 2009, Smoking cessation in chronic obstructive pulmonary disease, Respir Med, 103, 963, 10.1016/j.rmed.2009.02.013 Tashkin, 2011, Effects of varenicline on smoking cessation in mild-to-moderate COPD: A randomized controlled trial, Chest, 139, 591, 10.1378/chest.10-0865 Wagena, 2005, Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease, Arch Intern Med, 165, 2286, 10.1001/archinte.165.19.2286 Jiménez Ruiz, 2012, Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications, Nicotine & Tobacco Research, 9, 1035, 10.1093/ntr/nts001 Global Strategy for the Diagnosis. Management and Prevention of COPD, Global Initiative for Chronic Obstructive Luna Disease (GOLD) 2011. Disponible en http://www.goldcopd.org Tashkin, 2011, Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients, Respir Med, 105, 1682, 10.1016/j.rmed.2011.04.016